| pubmed-article:21343836 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21343836 | lifeskim:mentions | umls-concept:C0346647 | lld:lifeskim |
| pubmed-article:21343836 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
| pubmed-article:21343836 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
| pubmed-article:21343836 | lifeskim:mentions | umls-concept:C0442034 | lld:lifeskim |
| pubmed-article:21343836 | lifeskim:mentions | umls-concept:C0521447 | lld:lifeskim |
| pubmed-article:21343836 | lifeskim:mentions | umls-concept:C0144576 | lld:lifeskim |
| pubmed-article:21343836 | lifeskim:mentions | umls-concept:C0332161 | lld:lifeskim |
| pubmed-article:21343836 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:21343836 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
| pubmed-article:21343836 | lifeskim:mentions | umls-concept:C1999216 | lld:lifeskim |
| pubmed-article:21343836 | lifeskim:mentions | umls-concept:C0302350 | lld:lifeskim |
| pubmed-article:21343836 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:21343836 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
| pubmed-article:21343836 | lifeskim:mentions | umls-concept:C0205221 | lld:lifeskim |
| pubmed-article:21343836 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:21343836 | pubmed:dateCreated | 2011-4-12 | lld:pubmed |
| pubmed-article:21343836 | pubmed:abstractText | Paclitaxel (PTX) is a useful treatment for peritoneal dissemination of malignant tumors. However, chemoresistance due to PTX-induced nuclear factor ?B (NF-?B) activation is an important cause of suboptimal therapeutic effect. We previously reported nafamostat mesilate (FUT175) inhibits NF-?B activation and promotes apoptosis in pancreatic cancer. We hypothesized that addition of FUT175 to PTX may enhance the antitumor effect in peritoneal dissemination of pancreatic cancer. | lld:pubmed |
| pubmed-article:21343836 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21343836 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21343836 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21343836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21343836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21343836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21343836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21343836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21343836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21343836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21343836 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21343836 | pubmed:month | May | lld:pubmed |
| pubmed-article:21343836 | pubmed:issn | 1536-4828 | lld:pubmed |
| pubmed-article:21343836 | pubmed:author | pubmed-author:YanagaKatsuhi... | lld:pubmed |
| pubmed-article:21343836 | pubmed:author | pubmed-author:OhashiToyaT | lld:pubmed |
| pubmed-article:21343836 | pubmed:author | pubmed-author:UwagawaTadash... | lld:pubmed |
| pubmed-article:21343836 | pubmed:author | pubmed-author:MisawaTakeyuk... | lld:pubmed |
| pubmed-article:21343836 | pubmed:author | pubmed-author:ShibaHiroakiH | lld:pubmed |
| pubmed-article:21343836 | pubmed:author | pubmed-author:ShimadaYohtaY | lld:pubmed |
| pubmed-article:21343836 | pubmed:author | pubmed-author:IidaTomonoriT | lld:pubmed |
| pubmed-article:21343836 | pubmed:author | pubmed-author:FurukawaKenei... | lld:pubmed |
| pubmed-article:21343836 | pubmed:author | pubmed-author:FujiwaraYukiY | lld:pubmed |
| pubmed-article:21343836 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21343836 | pubmed:volume | 40 | lld:pubmed |
| pubmed-article:21343836 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21343836 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21343836 | pubmed:pagination | 600-7 | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:meshHeading | pubmed-meshheading:21343836... | lld:pubmed |
| pubmed-article:21343836 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21343836 | pubmed:articleTitle | Combination paclitaxel and inhibitor of nuclear factor ?B activation improves therapeutic outcome for model mice with peritoneal dissemination of pancreatic cancer. | lld:pubmed |
| pubmed-article:21343836 | pubmed:affiliation | Department of Surgery, Institute of DNA Medicine, Jikei University School of Medicine, Minato-ku, Tokyo, Japan. sheetan@jikei.ac.jp | lld:pubmed |
| pubmed-article:21343836 | pubmed:publicationType | Journal Article | lld:pubmed |
